Showing 1 - 10 of 70
Background: Treatment of chronic illness accounts for over 90% of Medicare spending. Chronic lymphedema places 3-10 million Americans at risk for recurrent cellulitis. Without convincing predictions of the costs and benefits of lymphedema treatment, insurers are reluctant to fully cover...
Persistent link: https://www.econbiz.de/10014489844
Persistent link: https://www.econbiz.de/10011695823
Persistent link: https://www.econbiz.de/10011696438
Approximately one in every thousand hospital patients dies because of preventable adverse events. Empirical findings …
Persistent link: https://www.econbiz.de/10010292511
Using a large set of private health insurance claims, we estimate how physicians' financial incentives affect their treatment choices in heart attack management. Different insurance plans pay physicians different amounts for the same services, generating the required variation in financial...
Persistent link: https://www.econbiz.de/10011599689
Treatment of chronic illness accounts for over 90 % of Medicare spending. Chronic lymphedema places over 3 million Americans at risk of recurrent cellulitis. Health insurers and legislators have taken an active role in fighting attempts to mandate the treatment of lymphedema for fear that...
Persistent link: https://www.econbiz.de/10011803069
Patient navigation has expanded as a promising approach to improve cancer care coordination and patient adherence. This paper addresses the need to identify the evidence on the economic impact of patient navigation in colorectal cancer, following the Health Economic Evaluation Publication...
Persistent link: https://www.econbiz.de/10012010768
This study examines whether health care is affected by Baumol's cost disease in a scenario of no growth. Baumol's model implies that stagnant sectors are driven by wage increases in excess of productivity growth. But in a no growth economy the income is constant. It is investigated in two...
Persistent link: https://www.econbiz.de/10011849457
In his 2008 Journal of Health Economics paper, Jochen Hartwig claimed that Baumol's Cost Disease (BCD) theory could explain observed increases in health care expenditures in OECD countries. This paper replicates Hartwig's results and demonstrates that he tested the wrong hypothesis. When one...
Persistent link: https://www.econbiz.de/10012197924
Background: The Swedish Healthcare Act states that patients should have equal access to healthcare. This study addresses at how this translates to pharmacological treatment of adult spasticity, including injections with botulinum toxin A (BoNT-A) and pumps for intrathecal baclofen (ITB). To...
Persistent link: https://www.econbiz.de/10014489815